| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nail Diseases | 22 | 2020 | 142 | 11.97 | Why? |
| Onychomycosis | 10 | 2020 | 23 | 6.83 | Why? |
| Nails | 11 | 2020 | 143 | 5.21 | Why? |
| Nails, Malformed | 5 | 2018 | 12 | 3.10 | Why? |
| Dermatology | 15 | 2021 | 1999 | 3.00 | Why? |
| Biotin | 4 | 2019 | 52 | 2.98 | Why? |
| Dermatologic Surgical Procedures | 5 | 2020 | 138 | 2.92 | Why? |
| Skin Diseases | 14 | 2021 | 2509 | 2.58 | Why? |
| Antifungal Agents | 9 | 2020 | 1828 | 2.56 | Why? |
| Skin Neoplasms | 11 | 2020 | 1679 | 2.40 | Why? |
| Dermatologists | 5 | 2020 | 435 | 1.95 | Why? |
| Melanoma | 7 | 2020 | 1229 | 1.82 | Why? |
| Smoke | 3 | 2020 | 349 | 1.71 | Why? |
| Cosmetic Techniques | 3 | 2018 | 167 | 1.62 | Why? |
| Nail Biting | 2 | 2018 | 6 | 1.51 | Why? |
| Lichen Planus | 2 | 2020 | 60 | 1.49 | Why? |
| Bridged Bicyclo Compounds, Heterocyclic | 4 | 2018 | 77 | 1.23 | Why? |
| Boron Compounds | 4 | 2018 | 75 | 1.21 | Why? |
| Alopecia Areata | 2 | 2018 | 140 | 1.18 | Why? |
| Dermatologic Agents | 3 | 2020 | 489 | 1.13 | Why? |
| Psoriasis | 4 | 2020 | 1739 | 1.11 | Why? |
| Biopsy | 5 | 2020 | 2811 | 1.10 | Why? |
| Printing, Three-Dimensional | 2 | 2020 | 624 | 1.06 | Why? |
| Foot Dermatoses | 3 | 2018 | 112 | 0.93 | Why? |
| Shoes | 1 | 2021 | 10 | 0.92 | Why? |
| Jewelry | 1 | 2020 | 4 | 0.89 | Why? |
| Chin | 2 | 2018 | 14 | 0.89 | Why? |
| Toes | 3 | 2018 | 252 | 0.88 | Why? |
| Hand Hygiene | 3 | 2020 | 1493 | 0.88 | Why? |
| Fluconazole | 2 | 2018 | 145 | 0.86 | Why? |
| Melanosis | 1 | 2020 | 29 | 0.84 | Why? |
| Sea Urchins | 1 | 2019 | 2 | 0.83 | Why? |
| Brimonidine Tartrate | 1 | 2019 | 4 | 0.82 | Why? |
| Head Protective Devices | 1 | 2021 | 163 | 0.81 | Why? |
| Hemostasis, Surgical | 1 | 2019 | 29 | 0.79 | Why? |
| Hearing Disorders | 1 | 2020 | 62 | 0.79 | Why? |
| Soaps | 1 | 2020 | 134 | 0.78 | Why? |
| Drug Labeling | 1 | 2019 | 65 | 0.78 | Why? |
| Adrenergic alpha-2 Receptor Agonists | 1 | 2019 | 47 | 0.77 | Why? |
| Deafness | 1 | 2020 | 82 | 0.77 | Why? |
| Port-Wine Stain | 1 | 2018 | 8 | 0.76 | Why? |
| Laser Therapy | 2 | 2018 | 158 | 0.75 | Why? |
| Dermatitis, Contact | 1 | 2020 | 98 | 0.75 | Why? |
| Lasers, Dye | 1 | 2018 | 9 | 0.75 | Why? |
| Medication Adherence | 2 | 2018 | 1270 | 0.75 | Why? |
| Timolol | 1 | 2018 | 11 | 0.75 | Why? |
| Office Visits | 2 | 2020 | 489 | 0.75 | Why? |
| Bandages, Hydrocolloid | 1 | 2018 | 27 | 0.74 | Why? |
| Blindness | 1 | 2020 | 130 | 0.74 | Why? |
| Lipectomy | 1 | 2018 | 7 | 0.74 | Why? |
| Electrosurgery | 1 | 2018 | 35 | 0.73 | Why? |
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2018 | 19 | 0.73 | Why? |
| Silver Nitrate | 1 | 2017 | 10 | 0.73 | Why? |
| Patient Education as Topic | 2 | 2018 | 1476 | 0.72 | Why? |
| Reminder Systems | 1 | 2018 | 104 | 0.72 | Why? |
| Internship and Residency | 4 | 2020 | 4987 | 0.72 | Why? |
| Carcinoma, Merkel Cell | 1 | 2018 | 35 | 0.72 | Why? |
| Aminoquinolines | 1 | 2018 | 63 | 0.71 | Why? |
| Reagins | 1 | 2017 | 3 | 0.70 | Why? |
| Administration, Topical | 5 | 2019 | 272 | 0.70 | Why? |
| Deoxycholic Acid | 1 | 2017 | 17 | 0.70 | Why? |
| Dermoscopy | 2 | 2019 | 346 | 0.69 | Why? |
| Fingers | 2 | 2018 | 221 | 0.69 | Why? |
| Syphilis Serodiagnosis | 1 | 2017 | 30 | 0.68 | Why? |
| Cryosurgery | 1 | 2018 | 57 | 0.68 | Why? |
| Job Application | 1 | 2020 | 186 | 0.68 | Why? |
| Postoperative Hemorrhage | 1 | 2019 | 183 | 0.67 | Why? |
| Protective Clothing | 1 | 2021 | 468 | 0.67 | Why? |
| Fibroma | 1 | 2016 | 17 | 0.67 | Why? |
| Facial Muscles | 1 | 2016 | 33 | 0.66 | Why? |
| Subcutaneous Fat | 1 | 2018 | 94 | 0.66 | Why? |
| Cell Phone Use | 1 | 2017 | 106 | 0.66 | Why? |
| Vision Disorders | 1 | 2020 | 260 | 0.65 | Why? |
| Lip | 1 | 2016 | 61 | 0.64 | Why? |
| Ulcer | 1 | 2018 | 128 | 0.64 | Why? |
| Dermal Fillers | 1 | 2016 | 41 | 0.63 | Why? |
| Early Detection of Cancer | 2 | 2018 | 1956 | 0.63 | Why? |
| Neuromuscular Agents | 1 | 2016 | 87 | 0.62 | Why? |
| Sirolimus | 1 | 2018 | 240 | 0.62 | Why? |
| Nonprescription Drugs | 1 | 2016 | 78 | 0.61 | Why? |
| Self-Injurious Behavior | 2 | 2018 | 391 | 0.60 | Why? |
| Education, Medical, Graduate | 2 | 2020 | 2082 | 0.60 | Why? |
| Janus Kinase Inhibitors | 2 | 2020 | 682 | 0.60 | Why? |
| Academies and Institutes | 1 | 2019 | 539 | 0.60 | Why? |
| Physicians, Women | 1 | 2019 | 221 | 0.59 | Why? |
| Hyaluronic Acid | 1 | 2016 | 168 | 0.58 | Why? |
| Drug Costs | 1 | 2019 | 313 | 0.58 | Why? |
| Medicine, Traditional | 1 | 2016 | 189 | 0.57 | Why? |
| Erythema | 1 | 2019 | 400 | 0.57 | Why? |
| Pityriasis Rosea | 1 | 2017 | 130 | 0.56 | Why? |
| Botulinum Toxins, Type A | 1 | 2016 | 134 | 0.56 | Why? |
| Ethanol | 1 | 2020 | 533 | 0.55 | Why? |
| Hematoma | 1 | 2017 | 305 | 0.54 | Why? |
| Hand Sanitizers | 1 | 2020 | 397 | 0.54 | Why? |
| Telemedicine | 7 | 2021 | 25032 | 0.52 | Why? |
| Adalimumab | 1 | 2017 | 389 | 0.51 | Why? |
| Hand Disinfection | 2 | 2020 | 1671 | 0.50 | Why? |
| Secondary Prevention | 1 | 2018 | 762 | 0.50 | Why? |
| Masks | 3 | 2020 | 8528 | 0.49 | Why? |
| Consumer Behavior | 1 | 2019 | 544 | 0.49 | Why? |
| Faculty, Medical | 1 | 2019 | 595 | 0.49 | Why? |
| Humans | 78 | 2021 | 930598 | 0.49 | Why? |
| Syphilis | 1 | 2017 | 318 | 0.48 | Why? |
| Appointments and Schedules | 1 | 2020 | 1204 | 0.47 | Why? |
| Internet | 2 | 2020 | 6204 | 0.47 | Why? |
| Dermatitis, Atopic | 1 | 2020 | 714 | 0.46 | Why? |
| Equipment Contamination | 1 | 2021 | 1308 | 0.46 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.45 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2018 | 676 | 0.44 | Why? |
| Cell Phone | 1 | 2018 | 750 | 0.43 | Why? |
| Arthritis, Psoriatic | 1 | 2017 | 625 | 0.42 | Why? |
| Physician-Patient Relations | 1 | 2020 | 1266 | 0.40 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 1261 | 0.40 | Why? |
| Pregnancy Complications | 1 | 2021 | 1388 | 0.39 | Why? |
| Self Report | 2 | 2018 | 3802 | 0.39 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 3 | 2021 | 9706 | 0.39 | Why? |
| Neoplasm Recurrence, Local | 1 | 2016 | 1063 | 0.38 | Why? |
| Pneumonia, Viral | 15 | 2020 | 243684 | 0.38 | Why? |
| Academic Medical Centers | 2 | 2020 | 3088 | 0.38 | Why? |
| Disease Transmission, Infectious | 3 | 2021 | 9044 | 0.37 | Why? |
| Coronavirus Infections | 15 | 2020 | 253789 | 0.37 | Why? |
| Dietary Supplements | 2 | 2019 | 2251 | 0.37 | Why? |
| Pandemics | 17 | 2020 | 389249 | 0.37 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.36 | Why? |
| Infection Control | 4 | 2021 | 23131 | 0.36 | Why? |
| Cost of Illness | 1 | 2019 | 1903 | 0.35 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.34 | Why? |
| Diagnosis, Differential | 5 | 2020 | 7220 | 0.34 | Why? |
| Anesthesia | 1 | 2018 | 1236 | 0.33 | Why? |
| Medical Staff, Hospital | 1 | 2017 | 1258 | 0.32 | Why? |
| Photography | 2 | 2020 | 255 | 0.32 | Why? |
| Betacoronavirus | 15 | 2020 | 204454 | 0.31 | Why? |
| Habits | 2 | 2018 | 334 | 0.30 | Why? |
| Personal Protective Equipment | 5 | 2021 | 15978 | 0.30 | Why? |
| Pharmaceutical Preparations | 1 | 2020 | 1897 | 0.29 | Why? |
| Triazoles | 2 | 2018 | 440 | 0.27 | Why? |
| Medicare | 2 | 2020 | 1048 | 0.25 | Why? |
| United States | 8 | 2021 | 46150 | 0.24 | Why? |
| Physical Examination | 2 | 2018 | 755 | 0.24 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.23 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.23 | Why? |
| Hygroscopic Agents | 1 | 2020 | 4 | 0.22 | Why? |
| Administration, Oral | 2 | 2019 | 2340 | 0.21 | Why? |
| Female | 22 | 2021 | 380317 | 0.21 | Why? |
| Intraoperative Period | 1 | 2020 | 97 | 0.21 | Why? |
| Adrenal Cortex Hormones | 1 | 2018 | 6537 | 0.21 | Why? |
| Interleukin-23 | 1 | 2020 | 64 | 0.20 | Why? |
| Itraconazole | 2 | 2018 | 135 | 0.20 | Why? |
| Health Services Accessibility | 2 | 2020 | 10697 | 0.20 | Why? |
| Emollients | 1 | 2020 | 108 | 0.20 | Why? |
| Toxins, Biological | 1 | 2019 | 40 | 0.20 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.20 | Why? |
| Occupational Exposure | 1 | 2018 | 4742 | 0.19 | Why? |
| Beauty Culture | 1 | 2018 | 16 | 0.19 | Why? |
| Back | 1 | 2018 | 10 | 0.19 | Why? |
| Mycological Typing Techniques | 1 | 2018 | 38 | 0.19 | Why? |
| Plasma Gases | 1 | 2018 | 25 | 0.19 | Why? |
| Clinical Trials as Topic | 4 | 2020 | 7330 | 0.19 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.19 | Why? |
| Hypersensitivity, Delayed | 1 | 2019 | 81 | 0.18 | Why? |
| Pulse Therapy, Drug | 1 | 2018 | 137 | 0.18 | Why? |
| First Aid | 1 | 2019 | 127 | 0.18 | Why? |
| Fishes | 1 | 2018 | 99 | 0.18 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.18 | Why? |
| Hair Diseases | 1 | 2018 | 31 | 0.18 | Why? |
| Adsorption | 1 | 2018 | 261 | 0.17 | Why? |
| Blastomycosis | 1 | 2017 | 8 | 0.17 | Why? |
| House Calls | 1 | 2020 | 215 | 0.17 | Why? |
| Ageratina | 1 | 2016 | 1 | 0.17 | Why? |
| Sunflower Oil | 1 | 2016 | 1 | 0.17 | Why? |
| Tracheophyta | 1 | 2016 | 2 | 0.17 | Why? |
| Resins, Plant | 1 | 2016 | 9 | 0.17 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.17 | Why? |
| Administration, Cutaneous | 1 | 2018 | 229 | 0.17 | Why? |
| Air Pollutants, Occupational | 1 | 2018 | 108 | 0.17 | Why? |
| New York City | 3 | 2020 | 7432 | 0.17 | Why? |
| Tea Tree Oil | 1 | 2016 | 11 | 0.17 | Why? |
| Antitussive Agents | 1 | 2016 | 12 | 0.17 | Why? |
| Warts | 1 | 2017 | 59 | 0.17 | Why? |
| School Admission Criteria | 1 | 2020 | 203 | 0.17 | Why? |
| Treponema pallidum | 1 | 2017 | 42 | 0.16 | Why? |
| Nevus, Pigmented | 1 | 2017 | 54 | 0.16 | Why? |
| Adult | 14 | 2020 | 244371 | 0.16 | Why? |
| Microscopy, Confocal | 1 | 2018 | 343 | 0.16 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.16 | Why? |
| Carbon | 1 | 2018 | 269 | 0.16 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.16 | Why? |
| Hair | 1 | 2018 | 175 | 0.16 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 8811 | 0.16 | Why? |
| Insurance Coverage | 1 | 2020 | 348 | 0.16 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.15 | Why? |
| Skin Aging | 1 | 2016 | 55 | 0.15 | Why? |
| Plant Oils | 1 | 2016 | 86 | 0.15 | Why? |
| Lung Diseases, Fungal | 1 | 2017 | 167 | 0.15 | Why? |
| Mental Disorders | 1 | 2018 | 6742 | 0.15 | Why? |
| Neck | 1 | 2018 | 307 | 0.15 | Why? |
| Interleukin-17 | 1 | 2020 | 602 | 0.15 | Why? |
| Biofilms | 1 | 2018 | 304 | 0.15 | Why? |
| Consensus | 2 | 2020 | 6345 | 0.15 | Why? |
| Skin | 2 | 2018 | 2096 | 0.14 | Why? |
| Middle Aged | 12 | 2020 | 270681 | 0.14 | Why? |
| Male | 14 | 2020 | 367725 | 0.14 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2020 | 694 | 0.14 | Why? |
| Aged | 10 | 2020 | 215776 | 0.14 | Why? |
| Drug Administration Schedule | 2 | 2018 | 2324 | 0.14 | Why? |
| Anesthetics | 1 | 2018 | 196 | 0.14 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.14 | Why? |
| Personnel Selection | 1 | 2020 | 512 | 0.13 | Why? |
| Video Recording | 1 | 2020 | 786 | 0.13 | Why? |
| Hand Dermatoses | 1 | 2018 | 284 | 0.13 | Why? |
| User-Computer Interface | 1 | 2020 | 1068 | 0.13 | Why? |
| Anti-Infective Agents, Local | 1 | 2020 | 520 | 0.13 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.13 | Why? |
| Risk Management | 1 | 2021 | 1044 | 0.13 | Why? |
| Photochemotherapy | 1 | 2018 | 297 | 0.12 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.12 | Why? |
| Databases, Factual | 2 | 2019 | 6248 | 0.12 | Why? |
| Water | 1 | 2017 | 765 | 0.12 | Why? |
| History, 20th Century | 1 | 2019 | 1282 | 0.12 | Why? |
| Schools, Medical | 1 | 2020 | 793 | 0.12 | Why? |
| Cross-Sectional Studies | 4 | 2020 | 53120 | 0.12 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.12 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.12 | Why? |
| Patients | 1 | 2020 | 1167 | 0.12 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.12 | Why? |
| Immunologic Factors | 2 | 2020 | 4206 | 0.12 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.11 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.11 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.11 | Why? |
| Algorithms | 2 | 2019 | 7346 | 0.11 | Why? |
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 441 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Practice Patterns, Physicians' | 2 | 2020 | 4927 | 0.10 | Why? |
| Tomography, Optical Coherence | 1 | 2018 | 1008 | 0.10 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.10 | Why? |
| Health Care Costs | 1 | 2019 | 1007 | 0.10 | Why? |
| Continuity of Patient Care | 1 | 2020 | 1574 | 0.10 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.10 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 877 | 0.10 | Why? |
| Child | 5 | 2020 | 70012 | 0.10 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.10 | Why? |
| Risk Assessment | 3 | 2018 | 25439 | 0.10 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.10 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2020 | 2483 | 0.10 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.09 | Why? |
| Patient Compliance | 1 | 2018 | 1468 | 0.09 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.09 | Why? |
| Needs Assessment | 1 | 2018 | 2352 | 0.09 | Why? |
| Drug Approval | 1 | 2017 | 1325 | 0.09 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.09 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Health Surveys | 1 | 2018 | 2841 | 0.08 | Why? |
| Patient Care Team | 1 | 2021 | 3556 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.08 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.08 | Why? |
| Nanoparticles | 1 | 2018 | 2040 | 0.08 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.07 | Why? |
| Leadership | 1 | 2019 | 2241 | 0.07 | Why? |
| Plant Extracts | 1 | 2016 | 1514 | 0.07 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.07 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.07 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.07 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.06 | Why? |
| Communication | 1 | 2020 | 5206 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.06 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.06 | Why? |
| Triage | 1 | 2020 | 7151 | 0.06 | Why? |
| Pregnancy | 2 | 2021 | 23879 | 0.05 | Why? |
| Students, Medical | 1 | 2020 | 4032 | 0.05 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Animals | 2 | 2019 | 78931 | 0.05 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.05 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.05 | Why? |
| Hypertension | 2 | 2017 | 8895 | 0.04 | Why? |
| Blastomyces | 1 | 2017 | 6 | 0.04 | Why? |
| Child, Preschool | 2 | 2018 | 36283 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Placebo Effect | 1 | 2017 | 108 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Amphotericin B | 1 | 2017 | 256 | 0.04 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2019 | 23402 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |